BPC 157: The Cure for Tissue Repair? Spartan Peptides Supplement Marketer Welcomes Friendlier Regime Under RFK Jr. 12 19 2024 BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved BPC 157 Ligament: 1 Unsafe Truth The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA moves toward easing restrictions on certain peptides BioPharma Dive